Crossject
Develops emergency medications delivered via a needle-free auto-injector platform.
ALCJ | PA
Overview
Corporate Details
- ISIN(s):
- FR0004178614 (+6 more)
- LEI:
- 969500W1VTFNL2D85A65
- Country:
- France
- Address:
- 6 Rue Pauline Kergomard, 21000 dijon
- Website:
- https://www.crossject.com/en
- Sector:
- Manufacturing
Description
Crossject is a specialty pharmaceutical company focused on developing and commercializing medications for life-threatening emergency situations. The company's core technology is ZENEO®, a proprietary, pre-filled, single-use needle-free auto-injector. This platform is designed to enable patients or untrained caregivers to rapidly, safely, and reliably administer emergency treatments. Crossject's product pipeline targets critical conditions such as epileptic seizures, acute adrenal crisis, and severe allergic reactions (anaphylaxis), aiming to improve patient outcomes by simplifying drug delivery in urgent scenarios.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-10 14:15 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 182.7 KB | ||
| 2025-02-12 07:30 |
Crossject annonce le renouvellement de Patrick Alexandre et Isabelle Liebschutz…
|
French | 232.4 KB | ||
| 2025-02-12 07:30 |
Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebsch…
|
English | 220.9 KB | ||
| 2025-02-06 07:30 |
Réalisation des opérations annoncées en décembre 2024 relatives a la modificati…
|
French | 329.2 KB | ||
| 2025-02-06 07:30 |
COMPLETION OF THE TRANSACTIONS ANNOUNCED IN DECEMBER 2024 RELATING TO THE AMEND…
|
English | 257.2 KB | ||
| 2025-01-20 14:42 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 182.5 KB | ||
| 2024-12-31 09:57 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 182.5 KB | ||
| 2024-12-19 07:30 |
Crossject confirme la disponibilité opérationnelle de sa chaîne de fabrication …
|
French | 215.1 KB | ||
| 2024-12-19 07:30 |
Crossject confirms ZEPIZURE® supply chain readiness with another successful ISO…
|
English | 215.2 KB | ||
| 2024-12-11 08:38 |
Crossject annonce le succes d’une augmentation de capital reservee à une catégo…
|
French | 390.7 KB | ||
| 2024-12-11 08:38 |
Crossject announces the pricing of its reserved capital increase and warrants i…
|
English | 310.0 KB | ||
| 2024-12-10 19:15 |
Crossject annonce une augmentation de capital et une emission de bons de souscr…
|
French | 316.7 KB | ||
| 2024-12-10 19:15 |
Crossject launches reserved capital increase and warrants issuance for an aggre…
|
English | 233.3 KB | ||
| 2024-12-09 07:30 |
Crossject and the U.S. Department of Defense Relaunch Joint Research on Needle-…
|
English | 204.3 KB | ||
| 2024-12-09 07:30 |
Crossject et le Département américain de la Défense relancent leur coopération …
|
French | 214.0 KB |
Automate Your Workflow. Get a real-time feed of all Crossject filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Crossject
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Crossject via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-06-24 | N/A | Other | Buy | 20,000 | N/A |
| 2024-06-14 | N/A | Other | Other | 10,979 | 20,289.19 EUR |
| 2024-06-06 | N/A | Other | Other | 1,058,617 | 1,956,324.22 EUR |
| 2024-06-06 | N/A | Other | Other | 16,106 | 29,763.89 EUR |
| 2024-06-06 | N/A | Other | Other | 10,275 | 18,988.20 EUR |
| 2024-06-06 | N/A | Other | Other | 10,074 | 18,616.75 EUR |
| 2024-06-06 | N/A | Other | Buy | 5,536 | 10,230.53 EUR |
| 2023-03-06 | N/A | Other | Other | 22,859 | 75,434.70 EUR |